Evidence map›Paper›PMID 35969458›Full record

ArticleJMIR medical informatics2022

Evaluation of the Clinical, Technical, and Financial Aspects of Cost-Effectiveness Analysis of Artificial Intelligence in Medicine: Scoping Review and Framework of Analysis.

Jesus Gomez Rossi, Ben Feldberg, Joachim Krois, Falk Schwendicke

Abstract readScoping Review
In one paragraph

Article in JMIR medical informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Theoretical applications of artificial intelligence in smart infusion pump technology: Expert panel insights.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Surgical outcomes and patient-centred perioperative programs.Journal of clinical monitoring and computing · 2023
    Article
  13. Article
  14. Review
  15. AI in Pathology: What could possibly go wrong?Seminars in diagnostic pathology · 2023
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jesus Gomez RossiDepartment of Oral Diagnostics, Digital Health and Health Services Research, Charité-Universitätsmedizin, Berlin, Germany.ORCID https://orcid.org/0000-0003-0181-7357
Ben FeldbergDepartment of Oral Diagnostics, Digital Health and Health Services Research, Charité-Universitätsmedizin, Berlin, Germany.ORCID https://orcid.org/0000-0002-3912-070X
Joachim KroisDepartment of Oral Diagnostics, Digital Health and Health Services Research, Charité-Universitätsmedizin, Berlin, Germany.ORCID https://orcid.org/0000-0002-6010-8940
Falk SchwendickeDepartment of Oral Diagnostics, Digital Health and Health Services Research, Charité-Universitätsmedizin, Berlin, Germany.ORCID https://orcid.org/0000-0003-1223-1669

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCost-effectiveness analysis of artificial intelligence (AI) in medicine demands consideration of clinical, technical, and economic aspects to generate impactful research of a novel and highly versatile technology.

objectiveWe aimed to systematically scope existing literature on the cost-effectiveness of AI and to extract and summarize clinical, technical, and economic dimensions required for a comprehensive assessment.

methodsA scoping literature review was conducted to map medical, technical, and economic aspects considered in studies on the cost-effectiveness of medical AI. Based on these, a framework for health policy analysis was developed.

resultsAmong 4820 eligible studies, 13 met the inclusion criteria for our review. Internal medicine and emergency medicine were the clinical disciplines most frequently analyzed. Most of the studies included were from the United States (5/13, 39%), assessed solutions requiring market access (9/13, 69%), and proposed optimization of direct resources as the most frequent value proposition (7/13, 53%). On the other hand, technical aspects were not uniformly disclosed in the studies we analyzed. A minority of articles explicitly stated the payment mechanism assumed (5/13, 38%), while it remained unspecified in the majority (8/13, 62%) of studies.

conclusionsCurrent studies on the cost-effectiveness of AI do not allow to determine if the investigated AI solutions are clinically, technically, and economically viable. Further research and improved reporting on these dimensions seem relevant to recommend and assess potential use cases for this technology.

Indexed as

artificial intelligencecostcost-effectivenesseconomicsframeworkhealth policyresearch and developmentsystematic review

Identifiers

PMID35969458
PMCPMC9419048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.